BRAF and melanoma: MM ranks among the malignancies with the highest mutational burden and is classified into four genomic groups based on the presence of distinct oncogenic drivers: mutant BRAF (50% of all melanomas), mutant N-/K-/H-RAS (25%), mutant NF1 (15%), and triple-wildtype (5%) [3,4].